Drug Profile
Research programme: Hedgehog cell signaling pathway inhibitors - GliGene AB
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GliGene
- Class
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Solid-tumours in Sweden
- 14 Feb 2012 Early research in Solid tumours in Sweden (unspecified route)